Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Assets Average (2024 - 2025)

Historic Assets Average for Zenas BioPharma (ZBIO) over the last 2 years, with Q3 2025 value amounting to $307.6 million.

  • Zenas BioPharma's Assets Average changed N/A to $307.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.6 million, marking a year-over-year change of. This contributed to the annual value of $219.1 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Zenas BioPharma's Assets Average stood at $307.6 million.
  • Zenas BioPharma's Assets Average's 5-year high stood at $386.7 million during Q4 2024, with a 5-year trough of $307.6 million in Q3 2025.